Minds Navigating the Diagnosis of Mild Cognitive Impairment
NCT ID: NCT05690243
Last Updated: 2023-11-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
160 participants
INTERVENTIONAL
2023-10-01
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* is the video therapy user-friendly for veterans?
* does it improve veterans well-being and quality-of-life?
Veterans will be asked to attend nine 1 hour small group video sessions and will complete questionnaires before and after the sessions.
Researchers will compare the group of veterans that starts the video sessions right away with a group that waits before starting the video sessions.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group therapy delivered via video telehealth
Nine sessions of 60 min each group therapy delivered via telehealth
Group psychotherapy delivered via video telehealth
Small group psychotherapy using psychoeducation and skills training aimed at addressing modifiable factors in MCI.
Group therapy delivered via video telehealth - wait list control
Nine sessions of 60 min each group therapy delivered via telehealth after a waiting period.
Group psychotherapy delivered via video telehealth
Small group psychotherapy using psychoeducation and skills training aimed at addressing modifiable factors in MCI.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group psychotherapy delivered via video telehealth
Small group psychotherapy using psychoeducation and skills training aimed at addressing modifiable factors in MCI.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 60 or older
* diagnosis of MCI, diagnosed at least a month or longer prior to screening
* diagnosis of at least one cardiovascular risk factor (i.e., hypertension, diabetes mellitus II, hyperlipidemia/hypercholesterolemia, or obesity)
* self-reported cognitive complaint (i.e., "Do you have problems with your memory or thinking abilities?")
* self-reported difficulty adjusting to declines in cognitive functioning (i.e., "Have these problems with memory or thinking impacted you, your life, or others in your life?")
* English speaking, and (h) ability to provide written informed consent
Exclusion Criteria
* diagnosis of serious mental illness likely to impact cognition (i.e., schizophrenia or bipolar I disorder)
* acutely suicidal or homicidal
* actively psychotic
* active substance use disorder
* limited life expectancy due to a terminal medical condition
* receiving ongoing chemotherapy or radiation treatment at time of screening
* residing in an assisted living or residential care facility
* currently participating in another psychotherapy, health promotion intervention, or cognitive training program, and
* any significant changes to psychotropic medications or medications for memory and cognition in the past month. Participants prescribed psychotropic medications and medications for memory and cognition will be asked to stay on their current dosages for the duration of the study.
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Department of Defense
FED
Tuscaloosa Research & Education Advancement Corporation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lori Davis, MD
Associate Chief of Staff, Research Service, Tuscaloosa Veterans Affairs Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patricia Pilkinton, MD
Role: PRINCIPAL_INVESTIGATOR
Tuscaloosa Veterans Affairs Medical Center
Lindsay Jacobs, PhD
Role: PRINCIPAL_INVESTIGATOR
Tuscaloosa Veterans Affairs Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tuscaloosa VA Medical Center
Tuscaloosa, Alabama, United States
Salem VA Medical Center
Salem, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
170
Identifier Type: -
Identifier Source: org_study_id